Back to Studies PREVENTKD

Prevent Risks by Early interVEntion at Nighttime in Type 1 diabetes for Kidney Disease (PREVENTKD)

Researchers at Northwestern University are recruiting subjects for a trial to prevent the development of kidney disease in people with type I diabetes. The study’s main goal is to see if early treatment with ACE inhibitors (a widely prescribed type of blood pressure medication that has protective effects on the kidney) is beneficial to prevent the kidney complication of diabetes called microalbuminuria (abnormal spilling of protein in the urine).

Who is Eligible?

What do study participants have to do?

How will I be compensated?

How do I get more information?
Please contact our study coordinator by telephone at 312-503-2183, Monday – Friday 8 AM - 5 PM for additional information or visit our website at

October 29, 2008

[ Back to Studies Page ]

  Back to Studies Return to the Top of This Page

Last Updated: Wednesday October 29, 2008 14:08:54
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.